Boston Partners Has $37.45 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Boston Partners reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 23.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 124,771 shares of the company’s stock after selling 37,660 shares during the period. Boston Partners’ holdings in HCA Healthcare were worth $37,450,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. Legacy Investment Solutions LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $39,000. Whipplewood Advisors LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $31,000. Tidemark LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $36,000. Activest Wealth Management raised its holdings in shares of HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. increased its holdings in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after buying an additional 50 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of recent analyst reports. Royal Bank of Canada lowered their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. KeyCorp reduced their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Truist Financial reduced their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Trading Up 1.3 %

Shares of HCA Healthcare stock opened at $334.42 on Thursday. The company has a market capitalization of $82.34 billion, a price-to-earnings ratio of 15.22, a PEG ratio of 1.10 and a beta of 1.68. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The firm’s 50-day moving average price is $320.53 and its two-hundred day moving average price is $343.97.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the company earned $5.90 earnings per share. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is currently 13.11%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.